Related Experiment Video

Updated: Jul 12, 2026

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy
07:02

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy

Published on: September 9, 2020

Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Will there ever be a

Iacopo Olivotto1, Steve R Ommen, Martin S Maron

  • 1Referral Center for Myocardial Diseases, Department of Cardiology, Azienda Ospedaliera Universitaria Careggi, Florence, Italy. olivottoi@ao-careggi.toscana.it

Journal of the American College of Cardiology
|August 28, 2007
PubMed

Insights

Dynamic left ventricular outflow tract obstruction in hypertrophic cardiomyopathy (HCM) poses treatment challenges. Surgical myectomy and alcohol septal ablation (ASA) are options, but a direct comparison trial faces significant hurdles.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Clinical Research

Background:

  • Dynamic left ventricular outflow tract obstruction is a key feature of hypertrophic cardiomyopathy (HCM).
  • This obstruction predicts clinical decline and mortality in HCM patients.
  • Invasive septal reduction therapy, including surgical myectomy and alcohol septal ablation (ASA), is considered for severe, symptomatic cases refractory to medical management.

Purpose of the Study:

  • To analyze the controversy surrounding surgical myectomy versus ASA for HCM with outflow obstruction.
  • To identify practical challenges in designing a prospective randomized trial comparing myectomy and ASA.
  • To provide clarity on realistic clinical strategies for managing symptomatic HCM patients with outflow obstruction.

Main Methods:

  • Review and analysis of existing literature and clinical controversies regarding septal reduction therapies for HCM.
  • Identification and discussion of practical and logistical obstacles to conducting a powered, randomized trial comparing surgical myectomy and ASA.
  • Clinical strategy assessment based on current evidence and expert opinion.

Main Results:

  • Significant polarization exists within the cardiovascular community regarding the optimal choice between surgical myectomy and ASA.
  • A prospective, adequately powered randomized trial comparing long-term outcomes of myectomy versus ASA presents insurmountable practical challenges.
  • Current evidence and practical considerations suggest a need for nuanced clinical decision-making rather than a one-size-fits-all trial.

Conclusions:

  • Direct comparison of surgical myectomy and ASA via a randomized trial is practically infeasible.
  • Clinical strategies for symptomatic HCM with outflow obstruction require careful consideration of individual patient factors and procedural complexities.
  • Further debate and re-evaluation of evidence are necessary to guide the most appropriate use of septal reduction therapies.

More Related Videos

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...